Cite
Evolutionary Fitness of Relapsed Multiple Myeloma Patients Who Responded to Upfront Combination Therapy Including New Drugs.
MLA
Terragna, Carolina, et al. “Evolutionary Fitness of Relapsed Multiple Myeloma Patients Who Responded to Upfront Combination Therapy Including New Drugs.” Clinical Lymphoma, Myeloma & Leukemia, vol. 17, Feb. 2017, p. e12. EBSCOhost, https://doi.org/10.1016/j.clml.2017.03.020.
APA
Terragna, C., Martello, M., Santacroce, B., Solli, V., Pantani, L., Zamagni, E., Tacchetti, P., Zannetti, B. A., Mancuso, K., Marzocchi, G., Testoni, N., Ameli, G., Termini, R., Dico, F. A., Borsi, E., Martinelli, G., & Cavo, M. (2017). Evolutionary Fitness of Relapsed Multiple Myeloma Patients Who Responded to Upfront Combination Therapy Including New Drugs. Clinical Lymphoma, Myeloma & Leukemia, 17, e12. https://doi.org/10.1016/j.clml.2017.03.020
Chicago
Terragna, Carolina, Marina Martello, Barbara Santacroce, Vincenza Solli, Lucia Pantani, Elena Zamagni, Paola Tacchetti, et al. 2017. “Evolutionary Fitness of Relapsed Multiple Myeloma Patients Who Responded to Upfront Combination Therapy Including New Drugs.” Clinical Lymphoma, Myeloma & Leukemia 17 (February): e12. doi:10.1016/j.clml.2017.03.020.